{
  "compound": "CBD-rich cannabis oil (CBD:THC 20:1)",
  "condition": "DEPRESSION",
  "effect_size": "Moderate-large (Cohen's d = 0.71)",
  "study_type": "OBSERVATIONAL",
  "source": "NORML:DEPRESSION_OBSERVATIONAL_004",
  "participants": "279 cancer patients with comorbid depression",
  "year": 2019,
  "notes": "Cannabidiol for Depression in Cancer Patients: Supportive Care Cohort Study",
  "confidence": "medium",
  "abstract": "63% achieved clinically significant improvement (\u22654 point reduction); mean score 12.8 \u2192 7.3"
}